Tag Archives: KPV
GLP-1 in Ulcerative Colitis: 66.7% vs 25.3% at 12 Weeks
GLP-1 receptor agonist users with ulcerative colitis reached remission far more often than matched controls. Weight loss was not associated with it.
KPV Peptide Research Moves Into Metabolism: First Adipocyte Study Reported
KPV peptide work has centred on inflammation for nearly two decades. A new Tissue Cell paper reports the first look at what the tripeptide does to fat cell differentiation, in cultured cells and in a mouse model.